NZ511941A - Use of Mycobacterium phlei DNA in chemotherapeutic compositions - Google Patents

Use of Mycobacterium phlei DNA in chemotherapeutic compositions

Info

Publication number
NZ511941A
NZ511941A NZ511941A NZ51194199A NZ511941A NZ 511941 A NZ511941 A NZ 511941A NZ 511941 A NZ511941 A NZ 511941A NZ 51194199 A NZ51194199 A NZ 51194199A NZ 511941 A NZ511941 A NZ 511941A
Authority
NZ
New Zealand
Prior art keywords
mycobacterium phlei
chemotherapeutic compositions
dna
phlei dna
mycobacterium
Prior art date
Application number
NZ511941A
Other languages
English (en)
Inventor
Nigel C Phillips
Mario C Filion
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of NZ511941A publication Critical patent/NZ511941A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ511941A 1998-12-04 1999-12-03 Use of Mycobacterium phlei DNA in chemotherapeutic compositions NZ511941A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11101998P 1998-12-04 1998-12-04
US12732099P 1999-04-01 1999-04-01
PCT/CA1999/001157 WO2000033875A1 (en) 1998-12-04 1999-12-03 Chemotherapeutic composition and method

Publications (1)

Publication Number Publication Date
NZ511941A true NZ511941A (en) 2003-04-29

Family

ID=26808584

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ511941A NZ511941A (en) 1998-12-04 1999-12-03 Use of Mycobacterium phlei DNA in chemotherapeutic compositions

Country Status (11)

Country Link
EP (1) EP1135161B1 (https=)
JP (1) JP4380922B2 (https=)
AT (1) ATE276766T1 (https=)
AU (1) AU782335B2 (https=)
CA (1) CA2353905C (https=)
DE (1) DE69920506T2 (https=)
DK (1) DK1135161T3 (https=)
ES (1) ES2229792T3 (https=)
NZ (1) NZ511941A (https=)
PT (1) PT1135161E (https=)
WO (1) WO2000033875A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794368B1 (en) 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
CA2395493C (en) 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
CN105943559A (zh) * 2010-10-13 2016-09-21 特莱斯塔治疗知识产权公司 细菌核糖核酸细胞壁组合物及其制备和使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100533576B1 (ko) * 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법

Also Published As

Publication number Publication date
AU782335B2 (en) 2005-07-21
WO2000033875A1 (en) 2000-06-15
ATE276766T1 (de) 2004-10-15
CA2353905C (en) 2010-06-22
ES2229792T3 (es) 2005-04-16
AU1541200A (en) 2000-06-26
PT1135161E (pt) 2005-01-31
JP2002531524A (ja) 2002-09-24
DE69920506D1 (de) 2004-10-28
EP1135161A1 (en) 2001-09-26
JP4380922B2 (ja) 2009-12-09
EP1135161B1 (en) 2004-09-22
CA2353905A1 (en) 2000-06-15
DE69920506T2 (de) 2005-10-13
DK1135161T3 (da) 2005-01-24

Similar Documents

Publication Publication Date Title
IL117642A (en) Ternary radiopharmaceutical complexes, kits comprising them and their use in radioimaging
IL180924A0 (en) Method for regulating cell proliferation and cell death
EP1339829A4 (en) DRY POWDER CELLS, CELL CULTURE REAGENTS, AND CORRESPONDING METHODS OF PRODUCTION THEREOF
ATE193554T1 (de) Telomerase-aktivitätsversuche
NO20001282L (no) Batteripakke og elektroverktøy
IL143529A0 (en) An electrolysis cell and methods utilizing the same
IL81168A0 (en) Haloarylnitrile degrading gene,its use,and cells containing the same
GB2296125B (en) Pre-graphitic carbonaceous insertion compounds and use as anodes in rechargeable batteries
EP1159402A4 (en) CELLS RESISTANT TO TOXIC GENES AND THEIR USE
GB2280779B (en) Electrochemical cell
IL108572A0 (en) Electrochemical cell
EP0115688A3 (en) Reaction sintered cermet and use thereof in electrolytic cell in aluminum reaction
EP1339127A4 (en) FESTPOLYMER ELECTROLYTE AND CELL WITH THE ELECTROLYTE
GB2338452B (en) Expanding envelope with a utility pocket
GB9809964D0 (en) Electrochemical cell
DK1035599T3 (da) Batteripakke og elværktöj
NZ511941A (en) Use of Mycobacterium phlei DNA in chemotherapeutic compositions
AU1677700A (en) Carbon dioxide scrubber in metal-air battery cells
GB9902776D0 (en) Materials and methods relating to a cancer cell marker
GR3025500T3 (en) Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent.
ZA985735B (en) The transfer of nucleic acid into the cells of pluricellular eukaryotic organisms and combination allowing the method to be carried out
IL91923A0 (en) Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
GB9314760D0 (en) Improvements in or relating to electrochemical cells
GB2353419B (en) Improvements in or relating to battery chargers and to circuits for use therewith
GB8924450D0 (en) Antitumour agent and tumour cell metastatis suppressive agent

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: BIONICHE UROLOGY IP INC., CA

Free format text: OLD OWNER(S): BIONICHE LIFE SCIENCES INC.

RENW Renewal (renewal fees accepted)
EXPY Patent expired